Pfizer Acquires King Pharmaceuticals to Add Pain Drugs

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Oct. 12 (Bloomberg) -- Pfizer Inc. agreed to pay $3.6 billion in cash to buy King Pharmaceuticals Inc., expanding its range of pain treatments to include tamper-resistant medicines. Pfizer, the world’s largest drugmaker, will pay $14.25 a share, a premium of 40 percent over King’s closing share price yesterday, the New York-based company said today in a statement. Bloomberg's Shannon Pettypiece talks with Betty Liu about the transaction on Bloomberg Television's "In the Loop." (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change